Activity and Tissue Distribution of Antisense Oligonucleotide CT102 Encapsulated with Cytidinyl/Cationic Lipid against Hepatocellular Carcinoma-Reference-Cited by-同舟云学术

Activity and Tissue Distribution of Antisense Oligonucleotide CT102 Encapsulated with Cytidinyl/Cationic Lipid against Hepatocellular Carcinoma

Published:2022-05-04 Issue:12 Volume:19 Page:4552-4564
ISSN:1543-8384
Container-title:Molecular Pharmaceutics
language:en
Short-container-title:Mol. Pharmaceutics

Author:

Guan Jing¹,Pan Yufei²^ORCID,Li Huantong²,Zhu Yuejie²,Gao Yujing²,Wang Jie²,Zhou Ying¹³,Guan Zhu²,Yang Zhenjun²³^ORCID

Affiliation:

1. Key Laboratory of Plant Resource Conservation and Germplasm Innovation in Mountainous Region (Ministry of Education), College of Life Sciences/Institute of Agro-bioengineering, Guizhou University, Guiyang 550025, China

2. State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University, Beijing 100191, China

3. College of Pharmaceutical Sciences, Guizhou University of Traditional Chinese Medicine, Guian New Area 550025, China

Funder

Ministry of Science and Technology of the People's Republic of China

National Natural Science Foundation of China

Industrial Funding for Beijing Joint Laboratory of Nucleic Acid Drugs beyond Peking University Medicine-Harbin Pharmaceutical Group

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Pharmaceutical Science,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.molpharmaceut.2c00026

Reference43 articles.

1. Molecular therapies and precision medicine for hepatocellular carcinoma

2. Cancer statistics, 2019

3. Hepatocellular Carcinoma

4. Growth factor receptors as therapeutic targets: strategies to inhibit the insulin-like growth factor I receptor

5. Advances in the early diagnosis of hepatocellular carcinoma

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bis-2′-F-cGSASMP isomers encapsulated in cytidinyl/cationic lipids act as potent in situ autologous tumor vaccines;Molecular Therapy;2024-06

2. Advances in tumor vascular growth inhibition;Clinical and Translational Oncology;2024-03-20

3. Design and synthesis of nucleotidyl lipids and their application in the targeted delivery of siG12D for pancreatic cancer therapy;Biomedicine & Pharmacotherapy;2024-03

4. Modified ASO conjugates encapsulated with cytidinyl/cationic lipids exhibit more potent and longer-lasting anti-HCC effects;Molecular Therapy - Nucleic Acids;2023-06

5. Nonviral delivery systems for antisense oligonucleotide therapeutics;Biomaterials Research;2022-09-30